SS Innovations International, Inc. 8K
0001213900-26-098588
View on SEC EDGARSS Innovations International, Inc. issued an operations update detailing rapid global adoption and utilization of its SSi Mantra surgical robotic system, record-setting telesurgeries, growing pediatric use, and anticipated U.S. and EU regulatory milestones.
On September 10, 2026, SS Innovations International, Inc. announced an operational update highlighting continued global expansion and adoption of its SSi Mantra surgical robotic system, including new installations and first-of-their-kind procedures in Colombia and Sri Lanka, progress in pediatric robotic surgery, and record-setting long-distance telesurgeries between Colombia and India as well as within the Philippines and across India. The company reported that, with the first installation in Sri Lanka, its installed base now reaches 238 systems across 12 countries and has supported 14,103 multi-specialty robotic procedures as of September 8, 2026, alongside training approximately 1,500 physicians and achieving 258 pediatric robotic surgeries and 188 telesurgeries by August 31, 2026. SS Innovations also noted increasing system utilization and scalability, such as 50 robot-assisted surgeries in a single day at a hospital in India and multiple practices surpassing key procedure-count milestones, and provided regulatory timelines, expecting FDA 510(k) review completion for SSi Mantra by the end of Q1 2027 and CE marking in the EU by the end of 2026.
Filing Facts
- CIK
- 1676163
- Ticker
- -
- Form
- 8K
- Source Type
- sec
- Accession
- 0001213900-26-098588
- Alert Tier
- 6